NUAgo Therapeutics, Inc.
Northwestern Inventor:
Marcus Peter
Feinberg School of Medicine
Medicine and Biochemistry & Molecular Genetics
NUAgo is developing single construct short RNAs that kill tumor cells selectively as a therapy for treatment resistant cancers.